BackEnanta Pharmaceuticals Overview

Enanta Pharmaceuticals Total Assets

Latest total assets for ENTA: $310M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$314.70M
2.57% YoYΔ $-8.29M vs prior year quarter

Peer average

Loading

Enanta Pharmaceuticals Total Assets History

Loading

Enanta Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Enanta Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Enanta Pharmaceuticals (ENTA) FAQ

As of the most recent data (March 2026), ENTA shows a total assets of $310M. That compares with $320M in the prior-year period — down 2.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ENTA's total assets is now $310M (was $320M) — a 2.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Enanta Pharmaceuticals is outperforming or lagging.

Tracking ENTA's total assets over time shows whether Enanta Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $310M That compares with $320M in the prior-year period — down 2.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Enanta Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $310M) with ownership activity and broader fundamentals.

Enanta Pharmaceuticals's total assets is $310M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.